AEON Biopharma (AEON) Competitors $0.76 +0.01 (+1.60%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$0.79 +0.03 (+3.95%) As of 04:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEON vs. MDCX, DYAI, IMA, ITRM, BCAB, RNTX, MAAQ, XCUR, RVPH, and KZRShould you be buying AEON Biopharma stock or one of its competitors? The main competitors of AEON Biopharma include Medicus Pharma (MDCX), Dyadic International (DYAI), ImageneBio (IMA), Iterum Therapeutics (ITRM), BioAtla (BCAB), Rein Therapeutics (RNTX), Mana Capital Acquisition (MAAQ), Exicure (XCUR), Reviva Pharmaceuticals (RVPH), and Kezar Life Sciences (KZR). These companies are all part of the "pharmaceutical products" industry. AEON Biopharma vs. Its Competitors Medicus Pharma Dyadic International ImageneBio Iterum Therapeutics BioAtla Rein Therapeutics Mana Capital Acquisition Exicure Reviva Pharmaceuticals Kezar Life Sciences Medicus Pharma (NASDAQ:MDCX) and AEON Biopharma (NASDAQ:AEON) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, media sentiment, analyst recommendations, risk, institutional ownership, profitability and earnings. Which has preferable earnings & valuation, MDCX or AEON? Medicus Pharma is trading at a lower price-to-earnings ratio than AEON Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicus PharmaN/AN/A-$11.16M-$1.34-1.81AEON BiopharmaN/AN/A-$36.63M-$6.08-0.13 Do analysts prefer MDCX or AEON? Medicus Pharma presently has a consensus price target of $23.50, indicating a potential upside of 867.08%. AEON Biopharma has a consensus price target of $360.00, indicating a potential upside of 47,268.42%. Given AEON Biopharma's higher possible upside, analysts plainly believe AEON Biopharma is more favorable than Medicus Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicus Pharma 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.20AEON Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer MDCX or AEON? In the previous week, Medicus Pharma had 6 more articles in the media than AEON Biopharma. MarketBeat recorded 7 mentions for Medicus Pharma and 1 mentions for AEON Biopharma. AEON Biopharma's average media sentiment score of 0.99 beat Medicus Pharma's score of 0.51 indicating that AEON Biopharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medicus Pharma 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AEON Biopharma 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of MDCX or AEON? 22.8% of AEON Biopharma shares are owned by institutional investors. 11.2% of Medicus Pharma shares are owned by company insiders. Comparatively, 0.9% of AEON Biopharma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is MDCX or AEON more profitable? AEON Biopharma's return on equity of 0.00% beat Medicus Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Medicus PharmaN/A -549.30% -228.06% AEON Biopharma N/A N/A -994.63% SummaryMedicus Pharma beats AEON Biopharma on 8 of the 13 factors compared between the two stocks. Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEON vs. The Competition Export to ExcelMetricAEON BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.85M$857.31M$5.78B$10.27BDividend YieldN/A4.84%5.74%4.64%P/E Ratio4.221.2076.5226.98Price / SalesN/A26.49546.03182.41Price / CashN/A19.5637.1760.63Price / Book-0.186.7013.886.37Net Income-$36.63M-$4.03M$3.29B$271.46M7 Day Performance-2.56%-1.48%1.60%2.53%1 Month Performance3.97%10.17%6.89%9.42%1 Year Performance-98.45%19.18%82.40%30.16% AEON Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEONAEON Biopharma3.3958 of 5 stars$0.76+1.6%$360.00+47,268.4%-98.4%$8.85MN/A4.225MDCXMedicus Pharma2.0999 of 5 stars$2.09+11.2%$23.50+1,024.4%N/A$33.49MN/A-1.56N/ANews CoverageGap UpDYAIDyadic International2.4996 of 5 stars$0.97+6.1%$6.00+521.7%-15.4%$32.93M$3.42M-5.087High Trading VolumeIMAImageneBio2.6376 of 5 stars$9.29+16.7%$35.50+282.1%-58.1%$32M$9.16M-1.2170High Trading VolumeITRMIterum Therapeutics2.8573 of 5 stars$0.66-2.6%$9.00+1,263.0%-37.7%$31.99MN/A-0.7810News CoveragePositive NewsShort Interest ↓Gap UpBCABBioAtla0.566 of 5 stars$0.61+13.9%$5.00+718.1%-58.4%$31.50M$11M-0.5660High Trading VolumeRNTXRein Therapeutics0.7797 of 5 stars$1.34+0.8%N/AN/A$31MN/A-0.509Gap DownMAAQMana Capital AcquisitionN/A$3.71+0.6%N/A+1,278.1%$30.14MN/A0.001XCURExicure0.8093 of 5 stars$4.30-9.5%N/A+69.4%$30.01M$500K-1.1150Gap UpRVPHReviva Pharmaceuticals2.8821 of 5 stars$0.45+1.8%$5.20+1,063.3%-69.6%$29.85MN/A-0.695News CoverageKZRKezar Life Sciences3.6727 of 5 stars$4.01-1.5%$9.00+124.4%-34.8%$29.81M$7M-0.4160High Trading Volume Related Companies and Tools Related Companies MDCX Alternatives DYAI Alternatives IMA Alternatives ITRM Alternatives BCAB Alternatives RNTX Alternatives MAAQ Alternatives XCUR Alternatives RVPH Alternatives KZR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEON) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AEON Stock Alerts